跳至主要内容
临床试验/NCT07524166
NCT07524166已完成不适用

The Impact of Empowerment-Based Health Education on Self-Management in Patients With Type 2 Diabetes Mellitus: A Randomized Control Trial

Eotvos Lorand University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Glycated hemoglobin (HbA1c)

研究概览

简要总结

Empowerment-based education may offer a sustainable approach to type 2 diabetes management, yet rigorous evidence within the Chinese healthcare context was lacking.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosed with T2DM according to clinical record;
  • aged 40 years or older;
  • duration of diabetes of at least 6 months;
  • ability to communicate and complete questionnaires independently;
  • provision of written informed consent.

排除标准

  • presence of severe diabetes complications (e.g., renal failure, proliferative retinopathy, severe neuropathy);
  • diagnosis with other major chronic illnesses (e.g., cancer, severe heart failure);
  • pregnancy or lactation;
  • participation in other interventional studies during the trial period;
  • cognitive or psychiatric disorders that would impede participation.

研究组 & 干预措施

intervention group

Experimental

Empowerment-Based Health Education

干预措施: Empowerment-Based Health Education (Behavioral)

control group

No Intervention

regular care

结局指标

主要结局

Glycated hemoglobin (HbA1c)

时间窗: From enrollment to the end of treatment at 6 weeks

level of Glycated hemoglobin (HbA1c) , which aimed to reflect average blood glucose levels .

fasting plasma glucose (FPG)

时间窗: From enrollment to the end of treatment at 6 weeks

Lelel of Glycemic control, which reflects immediate glycemic status

次要结局

  • Diabetes-specific knowledge(From enrollment to the end of treatment at 6 weeks)
  • Self-efficacy(From enrollment to the end of treatment at 6 weeks)
  • diabetes self-management behaviors(From enrollment to the end of treatment at 6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Feifei Wang

Principal Investigator

Affiliated Hospital of Jiaxing University

研究点 (1)

Loading locations...

相似试验